Quick Summary

Nigella sativa, commonly known as Black Seed or black cumin, is a medicinal herb traditionally used for various health purposes. It contains bioactive compounds, primarily thymoquinone, that have been studied for their antioxidant, anti-inflammatory, antidiabetic, and hypolipidemic properties. Clinical evidence from randomized controlled trials and systematic reviews suggests potential benefits in glycemic and lipid control, metabolic syndrome, type 2 diabetes, pediatric applications, and certain inflammatory conditions. However, some findings are inconsistent or preliminary. Black Seed is generally well tolerated with mild or no serious adverse effects reported, but more high-quality research is needed to confirm its efficacy, optimal dosing, and safety profile.

What is it

Black Seed (Nigella sativa) is a flowering plant native to parts of South and Southwest Asia. Its seeds and oil have been used traditionally in herbal medicine and cooking. The seeds contain various bioactive compounds, of which thymoquinone is best studied for its pharmacological effects.

Traditional Uses

Historically, Black Seed has been used to support general health and treat a range of conditions including digestive issues, respiratory ailments, metabolic disorders, and inflammatory diseases. It is traditionally considered a remedy for enhancing immunity and overall vitality.

Active Compounds

  • Thymoquinone: The primary bioactive compound linked to many of the herb’s studied effects.
  • Other compounds include thymol, nigellidine, nigellicine, and various alkaloids and fatty acids.

Potential Benefits with Evidence Levels

  • Improvement in glycemic control and lipid profile in type 2 diabetes and metabolic syndrome (Moderate evidence):
    • Systematic reviews and meta-analyses report significant reductions in fasting blood glucose, HbA1c, total cholesterol, and LDL cholesterol. Some studies note minor improvements in HDL cholesterol.
    • References: PMID 40714301, PMID 40210172, PMID 41029669, PMID 39181437
  • Potential benefit in pediatric populations (Limited/Preliminary evidence):
    • Limited pediatric trials show improvements in clinical outcomes with no severe adverse effects, but data are insufficient to make firm clinical recommendations.
    • Reference: PMID 41112345
  • Reduction in symptoms and disease activity in polycystic ovary syndrome (PCOS) in adolescents (Preliminary evidence):
    • Short-term supplementation showed reduced ovarian volume, improved hormonal balance (lower LH and testosterone), and decreased menstrual irregularities.
    • Reference: PMID 38997723
  • Potential immunomodulatory and anti-inflammatory effects (Preclinical and clinical with mixed results):
    • Preclinical studies demonstrate anti-inflammatory properties, but clinical trials report conflicting results on inflammatory markers (e.g., VCAM-1, ICAM-1).
    • References: PMID 40365513, PMID 38915995, PMID 39816053
  • Potential analgesic and anti-inflammatory effects in osteoarthritis (Low to Moderate evidence):
    • Topical and oral Black Seed oil may reduce knee osteoarthritis pain; evidence is inconsistent and based on low-quality studies.
    • Reference: PMID 38650731
  • Potential benefits in allergic rhinitis (Limited evidence):
    • Some studies show improved nasal symptoms and treatment outcomes without significant adverse effects.
    • Reference: PMID 39372205

Side Effects

Black Seed is generally well tolerated in clinical trials with no serious adverse effects consistently reported. Mild and transient side effects such as gastrointestinal discomfort have been noted but were not statistically significant.

Drug Interactions

Evidence on drug interactions is limited. Due to its effects on blood glucose and lipid levels, caution and clinical monitoring are advised when used alongside antidiabetic and lipid-lowering medications until more data are available.

Who Should Avoid It

Use should be cautious or avoided where safety data are lacking, especially during pregnancy and breastfeeding, and in pediatric populations. There is insufficient evidence to define specific contraindications conclusively.

Evidence Limitations

  • Many clinical trials have small sample sizes, short durations, and heterogeneous study designs.
  • Variability exists in Nigella sativa preparations (oil, powder, capsules), dosages, and treatment durations, limiting comparability.
  • Lack of large, high-quality randomized controlled trials in diverse populations.
  • Inconsistent or insufficient data on long-term safety, drug interactions, and standardized dosing regimens.
  • Most data for some indications are preliminary or from preclinical studies, which limits clinical applicability.

References

Last Reviewed

June 2024

Informational Disclaimer: This content is for educational and informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your healthcare provider with any questions you may have regarding a medical condition or before starting any new supplement.